Exchange: NYSE·Updated 07:58 PM EDT
BHC logo

BHC Bausch Health Companies Inc

$8.20
$0.71
(7.97%)
Today
Closed $8.20
$0.02
(0.24%)
After Hours
Reported EarningsOct 28
Mkt Cap$3.07B
Vol8.87M

About BHC

Bausch Health Cos., Inc. engages in the development, manufacture and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. It operates through the following segments: Salix, International, Solta Medical, Diversified Products, and Bausch + Lomb. The Salix segment consists of sales in the U.S. of GI products. Sales of the Xifaxan product line. The International segment comprises of sales, except for sales of Bausch + Lomb products and Solta aesthetic medical devices, outside the U.S and Puerto Rico of branded pharmaceutical products, branded generic pharmaceutical and OTC products. The Solta Medical segment refers to global sales of Solta Medical aesthetic medical devices. The Diversified Products segment covers sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, generic products, ortho dermatologic, and dentistry products. The Bausch + Lomb segment are global sales of Bausch + Lomb vision care, surgical and ophthalmic pharmaceuticals products. The company was founded on March 29, 1994, and is headquartered in Laval, Canada.
80

Extremely Bullish Sentiment

How do you feel about BHC?

SadyK189
Top Stocks to watch tomorrow 2 / 2: $BHC $KPLT $JFIN $KPTI KPTI: Initially alerted at 0.53. Currently at 0.95. Still looking good on 4hours chart with updated support zone at 0.73 - 0.78. Next key level to test 1.12 - 1.25. BHC: Alerted at 7.58 yesterday. Currently at 8.70. Looking good on daily chart. Key support zone at 7.4 - 7.85. Next key level to test 9.8 - 10.25. KPLT: Looking good on daily chart. key support zone at 9.7 - 10.25. Next key level to test 12.6 - 13.10. Currently at 11.66 JFIN: Good close of daily candle. Key support zone at 1.3 - 1.45. Next key level to test 2.05 - 2.25. Currently at 1.71
6
Canuck1867
$BHC I've always been a fan of Brent and have to now believe with him gone BLCO will be aquired and not doing any aquiring which would have required keeping on a first rate CEO. Positive for shareholders in the end.....
9
lostmyshirt
$BHC My single worst investment that I truly believed in. I still believe it's worth $30+ per share. But it took a horrible turn when Papa dragged his feet for more than a year to finally try B&L ipo at the worst time. We are still in the course of correcting his mistakes. The future will become very clear and bright in 3 years when we retire $5B+ debt. Hopefully the share price doesn't take that long to reflect the value.
6
Canuck1867
$BHC Congrats to everyone who's been on this journey with me: Coolhat1, GreedyBunny, Gary1918, ContrarianD, FU2, ValueInvestor,Linley! ....and more. Paulson paid $9 for Icahn's stake. Hard to believe we've seen the best days yet for our share price.
6
GreedyBunny
$BHC so it’s interesting that Paulson is only allowed to own 20% of shares but if you retire 50m shares then his percentage will go above that to about 25%. I’m guessing no vote is needed in that scenario.
4
Contrarian_Dan
$BHC Wow! I definitely wasn't expecting this after hearing about Bausch & Lomb giving Brent Saunders a 75 million severance. If Teva can go from 7 bucks to 40, then so can BHC.
4
Coolhat1
$BHC $BLCO The price is discouraging to say the least but is completely meaningless a stock can trade at any price at anytime. There is great potential with this company. BLCO OVER 1 BILLION EBIDTA AND GUIDING FOR 1.3 BILLION BY 2028 WITH 3.5x LEVERAGE RATIO. ALL NEW TECH COMES OUT AFTER 2028 WHICH MEANS THIS IS A LONG HOLD. BHC STILL MAKING OVER 1.3 BILLION FREE CASHFLOW A YEAR AND GREAT MARGINS WITH SOLTA GROWING MID TEENS EVER YEAR CAGR. ITS GOING TO COME AROUND EVENTUALLY GIVE IT TIME DONT COME ON THIS CHAT TALKING NONSENSE WHEN YOU DONT UNDERSTAND THE FUNDAMENTALS OF THIS COMPANY PLEASE!!
5
gary918
$BHC I ran this through Chat and one scenario certainly has potential is the reintegration of BLCO into BHC. A lot of analysis and several ways to do this, but consolidating would provide an EBITDA of about $4B and a leverage ratio of about 5.5 with debt of approximately $21B. This could give a stock price of $18 - $26. IF that happened, then the Company could wait for the additional $1-$2 billion in additional revenue from BLCO to drive value. BHC is exercising additional control over BLCO and that probably suggests a change in strategic direction. Also, we are past the 2 year tax free restriction on consolidating the companies. The analysis looked at exchanging stock (BHC for BLCO) buying the 13% or consolidating for accounting purposes. Bottom line, this could get us back to the pre spin price while we wait for the additional revenue streams. Hopefully, we get some additional info on the earnings call.
5
Coolhat1
$BHC $BLCO what would it be trading at without the macro headwinds?? Record interest rates, high oil prices and rising bonds yields. This is being held down a lot by things outside its control while doing great fundamentally
3
AlertsAndNews
$BHC buy back and impressive EPS Bausch Health Announces US$50 Million Share Repurchase Program EPS $1.77 vs. $1.29 Est
3
ValueInvestor45
$BHC I have held this position since 2016, and it has been a continuous challenge. I have already liquidated 80 percent of the original holding over the past 3 years for tax loss harvesting, leaving just 20 percent remaining. My target is to fully exit the position before the end of the year. Will see what happens....
4
Contrarian_Dan
$BHC Its a bloodbath out there and this is green. Incredible. Maybe the ER will be good after all?
4
AKTN
$BHC $BLCO merge these two pieces of shit back together. Fk Papa out of his $2M IPO completion bonus. The guy already got paid $2M for the braindead idea. Shareholders need a piece of the donut machine collecting dust in the corner of Appio's office.
3
vcd103
$BHC nice day today after 5 years of 'turnaround of lifetime' bs. My updated Fibonacci levels are below •$10.32 (first target) •$11.95 (second target) •$13.75 (third target) •$16.66 (aggressive technical target) Technicals say those levels are achievable
2
Coolhat1
$BHC With there outstanding performance I think putting $BLCO back into bhc makes a lot of sense. APPIO has done a great job and on earning call stated when asked if managing both would be hard or take time away he stated they were once together a while ago. I personally feel like he is hinting at something
2
GreedyBunny
$BHC correction on a previous post. I thought they were doing a 50m share buyback. It’s a $50M dollars worth buyback.
2
btradingwarehouse
$BHC ...2BULLS... ... Champs !!! If you cried as I did use some Bausch products please We good...very good !!! ... Let's get down to business: 1. DO NOT BUY !!! 2. DO NOT START AVERAGING !!! 3. WAIT !!! ... Stay smart strong smile
2
gary918
$BHC The note redemption just announced will reduce the Balance Sheet by about $650 million as it was by cash and interest rate reduction expense gross by approximately $55 million.
2
SWIMHOLE
$BHC ran 70% in 2 days last ER beat on numbers less impressive. Last earnings it opened flat while beating EPS 25% and Rev 7%. They increased guidance for Q3. This earnings it beat EPS 40% and Rev 7%. This is on increased guidance and guided up rest of the year. I fully expect this to hit $10 by end of November. Will open almost flat and run multiple days.
2
Rpate
$BHC Company paid heavy price to Brent to move out because he might had been obstacle in M & A . We may expect some news on M & A very soon.
3

Advertisement|Remove ads.